Editorial: Advances in the Pathogenesis and Therapeutic Strategies for Nasopharyngeal Carcinoma.
作者信息
Yang Kai-Bin, Xu Cheng, Chen Yu-Pei, Vermorken Jan Baptist, O'Sullivan Brian, Ma Jun
机构信息
Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China.
State Key Laboratory of Oncology in South China, Department of Radiation Oncology, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.
出版信息
Front Oncol. 2021 Mar 9;11:647809. doi: 10.3389/fonc.2021.647809. eCollection 2021.
Abstract
摘要
相似文献
1
Editorial: Advances in the Pathogenesis and Therapeutic Strategies for Nasopharyngeal Carcinoma.社论：鼻咽癌发病机制与治疗策略的进展
Front Oncol. 2021 Mar 9;11:647809. doi: 10.3389/fonc.2021.647809. eCollection 2021.
2
Induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in stage III-IVb nasopharyngeal carcinoma patients with Epstein-Barr virus DNA ≥4000 copies/ml: a matched study.III-IVb期爱泼斯坦-巴尔病毒DNA≥4000拷贝/毫升的鼻咽癌患者中，诱导化疗后序贯同步放化疗与单纯同步放化疗的匹配研究。
Oncotarget. 2016 May 17;7(20):29739-48. doi: 10.18632/oncotarget.8828.
3
Nasopharyngeal carcinoma.鼻咽癌。
Lancet. 2019 Jul 6;394(10192):64-80. doi: 10.1016/S0140-6736(19)30956-0. Epub 2019 Jun 6.
4
Detection of Epstein-Barr virus DNA in formalin-fixed paraffin-embedded tissue of nasopharyngeal carcinoma using polymerase chain reaction and in situ hybridization.使用聚合酶链反应和原位杂交技术检测鼻咽癌福尔马林固定石蜡包埋组织中的EB病毒DNA
Laryngoscope. 1991 Mar;101(3):279-83. doi: 10.1288/00005537-199103000-00010.
5
Combination of Plasma MIF and VCA-IgA Improves the Diagnostic Specificity for Patients With Nasopharyngeal Carcinoma.联合检测血浆 MIF 和 VCA-IgA 对鼻咽癌患者的诊断特异性有提高作用。
Technol Cancer Res Treat. 2020 Jan-Dec;19:1533033820935773. doi: 10.1177/1533033820935773.
6
Survival analysis of patients with advanced-stage nasopharyngeal carcinoma according to the Epstein-Barr virus status.根据爱泼斯坦-巴尔病毒状态对晚期鼻咽癌患者进行生存分析。
Oncotarget. 2016 Apr 26;7(17):24208-16. doi: 10.18632/oncotarget.8144.
7
Detection of Epstein-Barr virus in metastatic lymph nodes of patients with nasopharyngeal carcinoma and a primary unknown carcinoma.在鼻咽癌及原发性不明癌患者转移性淋巴结中检测爱泼斯坦-巴尔病毒。
Arch Otolaryngol Head Neck Surg. 2003 Mar;129(3):338-40. doi: 10.1001/archotol.129.3.338.
8
Nasopharyngeal carcinoma with mastoid recurrence after concurrent chemoradiotherapy masquerading as acute otomastoiditis.同步放化疗后乳突复发的鼻咽癌伪装成急性中耳乳突炎。
Auris Nasus Larynx. 2017 Dec;44(6):754-757. doi: 10.1016/j.anl.2016.11.001. Epub 2016 Nov 22.
9
Prognostic Value of Plasma Epstein-Barr Virus DNA for Local and Regionally Advanced Nasopharyngeal Carcinoma Treated With Cisplatin-Based Concurrent Chemoradiotherapy in Intensity-Modulated Radiotherapy Era.在调强放射治疗时代，基于顺铂的同步放化疗治疗局部和区域晚期鼻咽癌时血浆EB病毒DNA的预后价值
Medicine (Baltimore). 2016 Feb;95(5):e2642. doi: 10.1097/MD.0000000000002642.
10
EBV based cancer prevention and therapy in nasopharyngeal carcinoma.基于EB病毒的鼻咽癌预防与治疗
NPJ Precis Oncol. 2017 May 15;1(1):10. doi: 10.1038/s41698-017-0018-x. eCollection 2017.
引用本文的文献
1
Targeting exosomes enveloped EBV-miR-BART1-5p-antagomiRs for NPC therapy through both anti-vasculogenic mimicry and anti-angiogenesis.通过抗血管生成拟态和抗血管生成靶向包裹 EBV-miR-BART1-5p-antagomiRs 的外泌体治疗 NPC。
Cancer Med. 2023 Jun;12(11):12608-12621. doi: 10.1002/cam4.5941. Epub 2023 Apr 25.
2
Identification of a 3-miRNA Signature Associated With the Prediction of Prognosis in Nasopharyngeal Carcinoma.鉴定与鼻咽癌预后预测相关的3种微小RNA特征
Front Oncol. 2022 Jan 27;11:823603. doi: 10.3389/fonc.2021.823603. eCollection 2021.
3
Baicalein Inhibits Metastatic Phenotypes in Nasopharyngeal Carcinoma Cells via a Focal Adhesion Protein Integrin β8.黄芩素通过粘着斑蛋白整合素β8抑制鼻咽癌细胞的转移表型。
Pharmaceuticals (Basel). 2021 Dec 21;15(1):5. doi: 10.3390/ph15010005.
本文引用的文献
1
Nasopharyngeal carcinoma.鼻咽癌。
Lancet. 2019 Jul 6;394(10192):64-80. doi: 10.1016/S0140-6736(19)30956-0. Epub 2019 Jun 6.
2
Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma.吉西他滨和顺铂诱导化疗治疗鼻咽癌。
N Engl J Med. 2019 Sep 19;381(12):1124-1135. doi: 10.1056/NEJMoa1905287. Epub 2019 May 31.
3
Concurrent chemoradiotherapy with/without induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma: Long-term results of phase 3 randomized controlled trial.同期放化疗联合/不联合诱导化疗治疗局部晚期鼻咽癌：III 期随机对照临床试验的长期结果。
Int J Cancer. 2019 Jul 1;145(1):295-305. doi: 10.1002/ijc.32099. Epub 2019 Jan 24.
4
Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods.估算 2018 年全球癌症发病率和死亡率：GLOBOCAN 来源和方法。
Int J Cancer. 2019 Apr 15;144(8):1941-1953. doi: 10.1002/ijc.31937. Epub 2018 Dec 6.
5
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018：GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
6
NCCN Guidelines Insights: Head and Neck Cancers, Version 1.2018.NCCN 指南解读：头颈部肿瘤，第 1.2018 版。
J Natl Compr Canc Netw. 2018 May;16(5):479-490. doi: 10.6004/jnccn.2018.0026.
7
The current status of clinical trials focusing on nasopharyngeal carcinoma: A comprehensive analysis of ClinicalTrials.gov database.聚焦鼻咽癌的临床试验现状：对 ClinicalTrials.gov 数据库的综合分析。
PLoS One. 2018 May 2;13(5):e0196730. doi: 10.1371/journal.pone.0196730. eCollection 2018.
8
A randomized trial of induction docetaxel-cisplatin-5FU followed by concomitant cisplatin-RT versus concomitant cisplatin-RT in nasopharyngeal carcinoma (GORTEC 2006-02).诱导多西紫杉醇-顺铂-5FU 序贯同期顺铂-RT 与同期顺铂-RT 治疗鼻咽癌的随机试验（GORTEC 2006-02）。
Ann Oncol. 2018 Mar 1;29(3):731-736. doi: 10.1093/annonc/mdx770.
9
International guideline for the delineation of the clinical target volumes (CTV) for nasopharyngeal carcinoma.国际鼻咽癌临床靶区勾画指南。
Radiother Oncol. 2018 Jan;126(1):25-36. doi: 10.1016/j.radonc.2017.10.032. Epub 2017 Nov 15.
10
Nasopharyngeal carcinoma incidence and mortality in China, 2013.2013年中国鼻咽癌的发病率和死亡率
Chin J Cancer. 2017 Nov 9;36(1):90. doi: 10.1186/s40880-017-0257-9.
Zotero 插件